INR 89.26
(-2.42%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.01 Billion INR | -38.67% |
2022 | 1.65 Billion INR | 16.39% |
2021 | 1.41 Billion INR | 31.42% |
2020 | 1.07 Billion INR | 1.6% |
2019 | 1.06 Billion INR | -21.02% |
2018 | 1.34 Billion INR | 38.37% |
2017 | 972.59 Million INR | 13.88% |
2016 | 854.08 Million INR | 1.57% |
2015 | 840.88 Million INR | 30.88% |
2014 | 642.48 Million INR | 8.5% |
2013 | 592.15 Million INR | 25.04% |
2012 | 473.55 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 230.47 Million INR | -26.4% |
2023 Q1 | 355.24 Million INR | -21.62% |
2023 FY | 1.01 Billion INR | -38.67% |
2023 Q4 | 313.13 Million INR | -29.6% |
2023 Q3 | 444.78 Million INR | 9.37% |
2023 Q2 | 406.67 Million INR | 14.48% |
2022 Q1 | 401.03 Million INR | 5.04% |
2022 FY | 1.65 Billion INR | 16.39% |
2022 Q4 | 453.25 Million INR | 12.31% |
2022 Q3 | 403.58 Million INR | 2.48% |
2022 Q2 | 393.83 Million INR | -1.79% |
2021 FY | 1.41 Billion INR | 31.42% |
2021 Q2 | 359.68 Million INR | 21.04% |
2021 Q4 | 381.78 Million INR | 0.33% |
2021 Q3 | 380.53 Million INR | 5.8% |
2021 Q1 | 297.15 Million INR | 93.26% |
2020 FY | 1.07 Billion INR | 1.6% |
2020 Q3 | 353.31 Million INR | 20.36% |
2020 Q2 | 293.55 Million INR | 5.12% |
2020 Q1 | 279.24 Million INR | 151.8% |
2020 Q4 | 153.75 Million INR | -56.48% |
2019 Q1 | 304.04 Million INR | 3.24% |
2019 FY | 1.06 Billion INR | -21.02% |
2019 Q4 | 110.89 Million INR | -66.14% |
2019 Q3 | 327.51 Million INR | 2.2% |
2019 Q2 | 320.44 Million INR | 5.4% |
2018 Q4 | 294.49 Million INR | -28.21% |
2018 FY | 1.34 Billion INR | 38.37% |
2018 Q3 | 410.19 Million INR | 18.21% |
2018 Q2 | 347.01 Million INR | 17.99% |
2018 Q1 | 294.09 Million INR | 82.44% |
2017 Q3 | 288.55 Million INR | 5.47% |
2017 Q1 | 250.13 Million INR | 0.0% |
2017 Q2 | 273.58 Million INR | 9.38% |
2017 Q4 | 161.2 Million INR | -44.13% |
2017 FY | 972.59 Million INR | 13.88% |
2016 FY | 854.08 Million INR | 1.57% |
2015 FY | 840.88 Million INR | 30.88% |
2014 FY | 642.48 Million INR | 8.5% |
2013 FY | 592.15 Million INR | 25.04% |
2012 FY | 473.55 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Hester Biosciences Limited | 908.84 Million INR | -11.467% |
Albert David Limited | 1.02 Billion INR | 1.276% |
Alembic Limited | 872.45 Million INR | -16.115% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.915% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.616% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -122.364% |
Bajaj HealthCare Limited | 985.34 Million INR | -2.813% |
FDC Limited | 3.49 Billion INR | 71.053% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.297% |
Gufic Biosciences Limited | 1.18 Billion INR | 14.624% |
Hikal Limited | 4.46 Billion INR | 77.305% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 52.308% |
Ind-Swift Limited | 946.56 Million INR | -7.024% |
Innova Captab Limited | 931.03 Million INR | -8.81% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -131.002% |
Jubilant Pharmova Limited | 14.45 Billion INR | 92.991% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -145.633% |
Laurus Labs Limited | 11.9 Billion INR | 91.494% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 5.691% |
Lupin Limited | 125.09 Billion INR | 99.19% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -524.466% |
Medico Remedies Limited | 59.67 Million INR | -1597.625% |
Morepen Laboratories Limited | 1.98 Billion INR | 49.027% |
Nectar Lifesciences Limited | 932.7 Million INR | -8.616% |
Orchid Pharma Limited | 800.77 Million INR | -26.51% |
Procter & Gamble Health Limited | 2.99 Billion INR | 66.18% |
RPG Life Sciences Limited | 1.63 Billion INR | 38.058% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 60.336% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.343% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 27.783% |
Themis Medicare Limited | 1.12 Billion INR | 10.014% |
Unichem Laboratories Limited | 6.72 Billion INR | 84.938% |
Vaishali Pharma Limited | 84.02 Million INR | -1105.605% |
Venus Remedies Limited | 1.91 Billion INR | 47.134% |
Wanbury Limited | 978.96 Million INR | -3.482% |
Windlas Biotech Limited | 1 Billion INR | -0.651% |
Ipca Laboratories Limited | 18.98 Billion INR | 94.665% |
Aarti Drugs Limited | 1.16 Billion INR | 13.227% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 67.049% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -14754.223% |
Brooks Laboratories Limited | 51.18 Million INR | -1879.402% |
Eris Lifesciences Limited | 4.94 Billion INR | 79.505% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 53.973% |
Sigachi Industries Limited | 579.88 Million INR | -74.699% |
Sakar Healthcare Limited | 204.07 Million INR | -396.405% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.18% |
Divi's Laboratories Limited | 14.17 Billion INR | 92.851% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 59.044% |
Mankind Pharma Limited | 29.27 Billion INR | 96.539% |
Sequent Scientific Limited | 2.9 Billion INR | 65.089% |
Neuland Laboratories Limited | 2.92 Billion INR | 65.422% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.152% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.842% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.191% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 51.622% |
Wockhardt Limited | 8.48 Billion INR | 88.054% |
Bal Pharma Limited | 555.62 Million INR | -82.327% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.943% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 28.619% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1638.021% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 53.412% |
Shilpa Medicare Limited | 3.33 Billion INR | 69.616% |
Valiant Laboratories Limited | 138.02 Million INR | -633.946% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.674% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -7027.686% |
Granules India Limited | 10.31 Billion INR | 90.177% |
Medicamen Biotech Limited | 335.16 Million INR | -202.255% |
Syncom Formulations (India) Limited | 345.63 Million INR | -193.102% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.408% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.271% |
NATCO Pharma Limited | 10.05 Billion INR | 89.928% |
Suven Life Sciences Limited | 109.75 Million INR | -823.06% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2094.857% |
Strides Pharma Science Limited | 9.16 Billion INR | 88.943% |
Indoco Remedies Limited | 12.06 Billion INR | 91.601% |
Alpa Laboratories Limited | 127.38 Million INR | -695.304% |
Lasa Supergenerics Limited | 291.17 Million INR | -247.922% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 67.074% |